2m 2m 2m 2m 2m 2m 2m
UNICYCIVE THERAP (UNCY)
NASDAQ
$5.77+$0.13 (+2.40%)
Price as of Aug 21, 2026 7:30 PM EDT- $156.8MMarket Cap
- 34.05%1-Year Change
- BiotechnologyIndustry
UNICYCIVE THERAP (UNCY)
$5.77+$0.13 (+2.40%)
UNCY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.63 | ||
Change | +$0.18 (+3.30%) | ||
Open | $5.51 | ||
High | $5.77 | ||
Low | $5.50 | ||
Previous Close | $5.45 | ||
Volume | 1,013,180 | ||
30-Day Average Volume | 775,924 | ||
1-Week Change | 2.18% | ||
1-Month Change | -1.05% | ||
1-Year Change | 34.05% | ||
3-Year Change | -31.27% | ||
5-Year Change | -78.43% | ||
Fundamentals | |||
Shares Outstanding | 27.9M | ||
Total Assets | $72.0M | ||
Market Cap | $156.8M | ||
Enterprise Value | $112.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.8M | ||
Free Cash Flow | -$7.6M | ||
EBIT | -$1.8M | ||
EBITDA | -$1.7M | ||
Net Working Capital | $52.6M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -65 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -94 | ||
PEG | -1 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/20/2025 | ||
Earnings & Revenue